Loading...
Abatacept as a Long-Term Targeted Therapy for LRBA Deficiency
BACKGROUND: Lipopolysaccharide-responsive beige-like anchor (LRBA) deficiency presents with susceptibility to infections, autoimmunity and lymphoproliferation. The long-term efficacy of CTLA4-Ig (abatacept) as targeted therapy for its immune dysregulatory features remains to be established. OBJECTIV...
Na minha lista:
| Udgivet i: | J Allergy Clin Immunol Pract |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6842687/ https://ncbi.nlm.nih.gov/pubmed/31238161 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaip.2019.06.011 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|